Gene · 3702
Papers2,789
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,789
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of key candidate genes and pathways in rheumatoid arthritis and osteoarthritis by integrated bioinformatical analysis. | Front Genet | 2023 | 36861127 | PubTator, text mining | PubMed |
| Identification and verification of feature biomarkers associated with immune cells in neonatal sepsis. | Eur J Med Res | 2023 | 36855207 | PubTator, text mining | PubMed |
| Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk. | Biochemistry | 2023 | 36854171 | PubTator, text mining | PubMed |
| PTCL, NOS: An update on classification, risk-stratification, and treatment. | Front Oncol | 2023 | 36845711 | PubTator, text mining | PubMed |
| Designing Next-Generation Drug-like Molecules for Medicinal Applications. | Molecules | 2023 | 36838848 | PubTator, text mining | PubMed |
| Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer. | Biomolecules | 2023 | 36830707 | PubTator, text mining | PubMed |
| Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma. | Antioxidants (Basel) | 2023 | 36830087 | PubTator, text mining | PubMed |
| Treatment of extranodal NK/T-cell lymphoma: From past to future. | Front Immunol | 2023 | 36825002 | PubTator, text mining | PubMed |
| Recurrent Cellulitis Revealing Helicobacter cinaedi in Patient on Ibrutinib Therapy, France. | Emerg Infect Dis | 2023 | 36823687 | PubTator, text mining | PubMed |
| Novel Bruton's tyrosine kinase inhibitor TAS5315 suppresses the progression of inflammation and joint destruction in rodent collagen-induced arthritis. | PLoS One | 2023 | 36821545 | PubTator, text mining | PubMed |
| Prospective comprehensive profiling of immune responses to COVID-19 vaccination in patients on zanubrutinib therapy. | EJHaem | 2023 | 36819189 | PubTator, text mining | PubMed |
| Breast cancer tumor microenvironment affects Treg/IL-17-producing Treg/Th17 cell axis: Molecular and therapeutic perspectives. | Mol Ther Oncolytics | 2023 | 36816749 | PubTator, text mining | PubMed |
| Strategy toward Kinase-Selective Drug Discovery. | J Chem Theory Comput | 2023 | 36815703 | PubTator, text mining | PubMed |
| A Retrospective Study of Metastatic Renal Cell Carcinoma Patients With Brain Metastases. | Cureus | 2023 | 36811042 | PubTator, text mining | PubMed |
| Topological data analysis identifies molecular phenotypes of idiopathic pulmonary fibrosis. | Thorax | 2023 | 36808085 | PubTator, text mining | PubMed |
| Identification of molecular subtypes of ischaemic stroke based on immune-related genes and weighted co-expression network analysis. | IET Syst Biol | 2023 | 36802116 | PubTator, text mining | PubMed |
| Pathologic and molecular insights in nodal T-follicular helper cell lymphomas. | Front Oncol | 2023 | 36793612 | PubTator, text mining | PubMed |
| Emerging predictive biomarkers for novel therapeutics in peripheral T-cell and natural killer/T-cell lymphoma. | Front Immunol | 2023 | 36776886 | PubTator, text mining | PubMed |
| CARs and Drugs: Pharmacological Ways of Boosting CAR-T-Cell Therapy. | Int J Mol Sci | 2023 | 36768665 | PubTator, text mining | PubMed |
| Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature. | Cells | 2023 | 36766791 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3702/papers?page=20